Funder
Canadian Urological Association
Astellas Pharma
Subject
Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology
Reference54 articles.
1. Regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study;JAMA Oncol.,2018
2. Corner JL. Prostate cancer outcomes: the three questions;Glaser;Eur. Urol.,2015
3. Improving outcomes in high-risk prostate cancer with radiotherapy;Polkinghorn;Rep. Pract. Oncol. Radiother. J. Greatpoland Cancer Cent. Poznan Polish Soc. Radiat. Oncol.,2013
4. Volumetric image-guided conformal radiotherapy for localized prostate cancer: analysis of dosimetric and clinical factors affecting acute and late toxicity;Ingrosso;Rep. Pract. Oncol. Radiother. J. Greatpoland Cancer Cent. Poznan Polish Soc. Radiat. Oncol.,2018
5. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications;Wicki;J. Controll. Release: Off. J. Controll. Release Soc.,2015
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献